Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.

about

Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.Brivaracetam: a novel antiepileptic drug for focal-onset seizures.

P2860

Q39094490-55D3449D-86F6-4F1A-8588-DF9636741139 Q49253776-D490ED42-704B-4E53-A8CF-6598540A5BA1

P2860

Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.

Item

http://www.wikidata.org/entity/Q38922348

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.

@en

type

Item

label

Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.

@en

prefLabel

Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.

@en

P1476

Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.

@en

P2093

Sheridan M Hoy

http://www.w3.org/2001/XMLSchema#string

P2860

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Brivaracetam: a rational drug discovery success story

Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan

Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials

Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American E

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American

Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations.

Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.

P2888

s40263-016-0376-x

P304

761-772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40263-016-0376-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27503181

http://www.w3.org/2001/XMLSchema#string

P921

brivaracetam

Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.

about

P2860

P2860

Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921